
🇮🇳🇺🇸👨🔬 Applying medicinal chemistry & chemical biology to study epigenetics @DanNomura lab. 🎓PhD @UMN_MedChem. 🦮 Former CanDoCanines puppy raiser
Berkeley, CA
Joined February 2017
- Tweets241
- Following305
- Followers228
- Likes2.6K
Anand Divakaran retweeted
TP53:
- Discovered 45 years ago, most cited gene all time
- No therapies
- 500 million people currently living will die of TP53 mutant cancers without new therapies
Our Preprint:
- A general strategy for TP53 missense mutant cancers (majority) with prototype small molecules
Anand Divakaran retweeted
The new class of HHMI investigators average 3.9 papers as corresponding author in Cell, Nature, or Science. 26 out of 26 members of this group previously trained with a PI who is in the National Academy of Sciences or who was an HHMI investigator themselves.
Anand Divakaran retweeted
Congrats to @melissalim00 & @ThangDoCong on their @ACSCentSci paper on the discovery of a minimal degradative covalent handle that targets DCAF16 for rational design of monovalent degraders! Thanks @NovartisScience @TheMarkFdn! @UCB_Chemistry @berkeleyMCB pubs.acs.org/doi/10.1021/acs…
Anand Divakaran retweeted
Congrats to our postdocs Seong Ho (Johnny) Hong & @adivkrn on the discovery of a covalent recruiter against the CUL1 substrate adaptor protein SKP1 that targets a SKP1/substrate receptor interfacing C160 to enable PROTAC applications! @UCB_Chemistry @berkeleyMCB @TheMarkFdn pubs.acs.org/doi/10.1021/acs…
Anand Divakaran retweeted
New @biorxivpreprint from our lab by @Qian37774492 on a covalent 14-3-3 molecular glue with the transcription factors YAP and TAZ and using this glue as a 14-3-3 recruiter to sequester nuclear neo-substrates into the cytosol! Thanks to #AppleTreePartners & @themarkfdn
biorxiv.org/content/10.1101/…
Anand Divakaran retweeted
Excited to showcase our new @biorxivpreprint frm postdocs @floraliciaflor & @NafsikaForte on the discovery of covalent degraders of oncogenic transcription factor b-catenin (CTNNB1) via destabilization! @UCB_Chemistry @berkeleyMCB @TheMarkFdn
biorxiv.org/content/10.1101/…
Anand Divakaran retweeted
New paper from our lab by postdoc Seong Ho (Johnny ) Hong on the discovery of a covalent recruiter against the Cullin adapter protein SKP1 for targeted protein degradation applications! biorxiv.org/content/10.1101/…
Anand Divakaran retweeted
Back and recovered from a stimulating Bioorganic GRC Taking back a lot of new ideas and wonderful memories from catching up with lab alumni, old friends and new. with @adivkrn @ColeScholtz @norvailine @rche54 @EmilyDykhuizen Thanks @DanNomura!
Exciting news that missed Twitter last week: I finally had chapter 1 of my dissertation published as a review article on domain-selective BET inhibitors. Thanks @fewill26 and @DanHarki for the many edits on this monster! onlinelibrary.wiley.com/doi/…
Anand Divakaran retweeted
Our Monday morning gift to the TPD community...If you missed @DanNomura's seminar last week this is now available on our @YouTube channel: youtu.be/0V5M76FFbYw
Anand Divakaran retweeted
Congrats to @NafsikaForte for the publication of her paper in ACS Chemical Biology on the discovery of a covalent E2 ubiquitin conjugating enzyme UBE2D recruiter for PROTAC applications! Thanks to @NovartisScience. And thanks to @TheMarkFdn !
pubs.acs.org/doi/10.1021/acs…
Anand Divakaran retweeted
Grateful to see our work highlighted alongside leaders in the field @craigmcrews @IngridWertz @ChoudharyLab @SchreiberStuart in the exciting and exploding area of proximity-inducing modalities for drug discovery in @NatRevDrugDisc nature.com/articles/d41573-0…
Anand Divakaran retweeted
Proud to see @FrontierMeds announce FMC-376, a covalent inhibitor that directly, rapidly, and completely blocks both active and inactive forms of KRAS G12C to overcome non-response and resistance seen with prior generation KRAS G12C inhibitors! Yay!! globenewswire.com/news-relea…
Anand Divakaran retweeted
Excited to showcase our latest work by postdoc @NafsikaForte @UCB_Chemistry @berkeleyMCB & @NovartisScience on covalently recruiting E2 ubiquitin conjugating enzyme UBE2D for targeted protein degradation applications!! Also thanks to @TheMarkFdn! biorxiv.org/content/10.1101/…
Doing our due diligence celebrating @EthanToriki and @JPapatzimas getting this heroic piece of work out, great effort guys! – at Oakland, CA
Excited to present our @biorxivpreprint on chemical rational design of molecular glue degraders through a covalent handle targeting RNF126! Congrats to @EthanToriki & @JPapatzimas who led work w/@NovartisScience! & thanks to @TheMarkFdn ! biorxiv.org/content/10.1101/…
Anand Divakaran retweeted
Rational Chemical Design of Molecular Glue Degraders dlvr.it/ScG912
Anand Divakaran retweeted
I'm so excited to have this work coming out on our rational design of molecular glue degraders! We converted a number of inhibitors into glues with a simple covalent handle. Such a great project working alongside my good buddy @EthanToriki and under the guidance of @DanNomura!
Excited to present our @biorxivpreprint on chemical rational design of molecular glue degraders through a covalent handle targeting RNF126! Congrats to @EthanToriki & @JPapatzimas who led work w/@NovartisScience! & thanks to @TheMarkFdn ! biorxiv.org/content/10.1101/…
Anand Divakaran retweeted
Excited to present our @biorxivpreprint on chemical rational design of molecular glue degraders through a covalent handle targeting RNF126! Congrats to @EthanToriki & @JPapatzimas who led work w/@NovartisScience! & thanks to @TheMarkFdn ! biorxiv.org/content/10.1101/…
Anand Divakaran retweeted
Nice paper by @kevansf using ligand-observed 19F NMR for probing differential binding to KRas. A fun read.
pubs.acs.org/doi/10.1021/acs…
Anand Divakaran retweeted
New Smith Lab from @MedicalCollege of WI publication in @ACSBioMed Journal of Medicinal Chemistry: "Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening" doi.org/10.1021/acs.jmedchem…
#bromodomains #NMR #PBRM1 #SAR


















